European Archives - Page 836 of 1023 - European Medical Journal

Selvita to Present New Data from its Oncology Programs at the Upcoming AACR Annual Meeting 2017

Kraków, Poland, March 13, 2017 – Selvita (WSE:SLV), a clinical stage drug discovery and development company focused on innovative medicines for oncology…

An Association Between Klotho Deficiency and Kidney Function

STRONG links have been discovered between the soluble protein Klotho and the decline in kidney function. The Klotho protein, whose gene is named after…

Model Kidneys Give New Hope to Researchers

AN ANIMAL testing alternative may soon be available after researchers at Bingham University, Binghamton, New York, USA, achieved a breakthrough in the…

German Community of Gynecological Oncology (AGO) Acknowledges MammaPrint in Breast Cancer Guidelines as Having Level 1A Clinical Evidence

Irvine, CA, USA and Amsterdam, the Netherlands, March 08, 2017 – Agendia, Inc., a world leader in personalized medicine and molecular cancer diagnostics…

Mental Health Specialist Commends UK Grime Star’s Bravery on Depression

March 7, 2017 – Following recent news that reveals a quarter of men self-harm in order to cope with depression, UK grime artist Stormzy’s live television…

Osteoarthritis and Back Pain: The Weather Plays No Part

HISTORICALLY, symptoms associated with osteoarthritis and back pain have been thought to be exacerbated by adverse weather conditions. However, research…

Rheumatoid Arthritis Joint Pain Promoted by Novel T Cell

A UNIQUE type of T cell has been discovered in patients with rheumatoid arthritis (RA). Research conducted at the Brigham and Women’s Hospital (BWH)…

Pfizer Selects Turner & Townsend for Expansion of Its Clinical Research Unit in Belgium

Turner & Townsend, the global professional services consultancy, has successfully delivered the first of two fit outs on behalf of Pfizer Clinical…

March Madness

You blink once, and it’s the beginning of 2017. You blink again, and March is here, eagerly knocking on the door to announce its arrival after what feels…

New Results from Second Phase 3 Study Show Significant Efficacy of Guselkumab and Superiority Versus Humira® in Treatment of Moderate to Severe Plaque Psoriasis

Orlando, Florida, 3 March, 2017 ― Janssen Research & Development, LLC (Janssen) announced today new findings from two pivotal Phase 3 studies reporting…